Markets

Health Care Sector Update for 04/08/2015: RGLS, OCUL, ACT

Top Health-care stocks:

JNJ: flat

PFE: +0.3%

ABT: flat

MRK: +1.0%

AMGN: flat

Health-care shares were generally unchanged in pre-market trade Wednesday.

In health-care stocks news, Regulus Therapeutics ( RGLS ) shares rose in Wednesday's pre-market session after the biopharmaceutical company late Tuesday said its RG-125 (AZD4076) treatment for nonalcoholic steatohepatitis in patients with type 2 diabetes/pre-diabetes was selected as a clinical candidate by larger biopharmaceutical company AstraZeneca ( AZN ), resulting in a $2.5 million payment to Regulus from AstraZeneca.

Shares in the company were up 9.4% at $17.45 during pre-market trading . Over the past 52 weeks, the company was trading between $5.40 and $25.60.

Ocular Therapeutix, Inc . ( OCUL ) saw its price target lowered to $48 from $50 by RBC Capital while the firm retained its outperform rating.

Shares in the company were unchanged at $31.05 during pre-market trading. Over the past 52 weeks, the company has traded between $11.90 and $44.19.

And Rhythm, a biopharmaceutical company, and Actavis plc ( ACT ), a global pharmaceutical company, said they have initiated a Phase 2b clinical trial assessing the efficacy and safety of relamorelin, Rhythm's ghrelin agonist, for the treatment of gastroparesis in patients with type 1 and type 2 diabetes.

Shares in the company were unchanged at $295.56 during pre-market trading. Over the past 52 weeks, the company has traded between $184.71 and $317.72.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

OCUL AZN RGLS ACT

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More